The Batten disease protein CLN8 is a stereospecific acyltransferase in bis(monoacylglycero)phosphate biosynthesis
Open Access
- 15 September 2026
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (10) , 2068-2077
Abstract
Loss-of-function mutations in the endoplasmic reticulum membrane protein CLN8 cause Batten disease, a neurodegenerative lysosomal storage disorder. CLN8 acts with the lysosomal enzyme CLN5 to produce bis(monoacylglycero)phosphate (BMP), a signature lysosomal phospholipid with unique S , S stereochemistry. However, the role of CLN8 in this pathway has remained unclear. Here we establish that CLN8 is a glycerophosphoglycerol acyltransferase that catalyses the stereospecific acylation of S , S -glycerophosphoglycerol to generate S , S -lysophosphatidylglycerol, the CLN5 substrate in BMP synthesis. Cryo-electron microscopy structures define the CLN8 active site and support a ping-pong acyl transfer mechanism. Batten disease mutations impair CLN8 enzymatic activity and abolish BMP production in mice. Exogenous S , S -lysophosphatidylglycerol, but not the R , S stereoisomer, restores BMP synthesis in CLN8-deficient cells and mice and improves neurological phenotypes in cln8 mutant zebrafish. These findings define the function of CLN8, explain the biochemical basis of CLN8 Batten disease and establish BMP precursor supplementation as a proof-of-concept therapeutic strategy.Keywords
Funding Information
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Medical Research Council (MC_UU_00028)
- Academy of Medical Sciences (SBF0010/1078)
- NCL Foundation (NCL-Stiftung) Batten Disease Global Research Initiative
- Italian Ministry of Health
- University of Oulu Graduate School
- Research Council of Finland
- the Research Council of Finland
- the Research Council of Finland
- Fondazione Telethon (GSA23C003)
- Wellcome (220257/Z/20/Z)
This publication has 64 references indexed in Scilit:
- Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS)Genomics, 1992
- Glycerol reorientation during the conversion of phosphatidylglycerol to bis(monoacylglycerol)phosphate in macrophage-like RAW 264.7 cells.Journal of Biological Chemistry, 1991
- Metabolism of phosphatidylglycerol and bis(monoacylglycero)-phosphate in macrophage subcellular fractions.Journal of Biological Chemistry, 1990
- Conversion of phosphatidylglycerol to lyso(bis)phosphatidic acid by alveolar macrophagesThe FASEB Journal, 1987
- Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in the mouseJournal of Neurogenetics, 1987
- Production of Bis(monoacylglycero)phosphate from Phosphatidylglycerol in Isolated Liver Lysosomes of Chloroquine-Pretreated RatsHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1981
- Conversion of phosphatidylglycerol lipids to bis(monoacylglycero)phosphate in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Stereoconfiguration of bisphosphatidic and semilysobisphosphatidic acids from cultured hamster fibroblasts (BHK cells)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- The stereochemical configuration of lysobisphosphatidic acid from rat liver, rabbit lung and pig lungBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Novel stereoconfiguration in lyso-bis-phosphatidic acid of cultured BHK-cellsChemistry and Physics of Lipids, 1974